Display options
Cite
Kmietzyk HJ, Schröter P, Ernst K. Zur Problematik einer Polyneuropathie bei Methaqualon-Medikation. [The problem of polyneuropathy in methaqualone medication]. Psychiatr Neurol Med Psychol (Leipz). 1977;29(5):298-303
Kmietzyk, H. J., Schröter, P., & Ernst, K. (1977). Zur Problematik einer Polyneuropathie bei Methaqualon-Medikation. [The problem of polyneuropathy in methaqualone medication]. Psychiatrie, Neurologie, und medizinische Psychologie, 29(5), 298-303.
Kmietzyk, H J, et al. "Zur Problematik einer Polyneuropathie bei Methaqualon-Medikation." [The problem of polyneuropathy in methaqualone medication]. Psychiatrie, Neurologie, und medizinische Psychologie vol. 29,5 (1977): 298-303.
Kmietzyk HJ, Schröter P, Ernst K. Zur Problematik einer Polyneuropathie bei Methaqualon-Medikation. [The problem of polyneuropathy in methaqualone medication]. Psychiatr Neurol Med Psychol (Leipz). 1977 May;29(5):298-303. German. PMID: 882610.
Copy Download .nbib Format: NLM
Share it on

Psychiatr Neurol Med Psychol (Leipz). 1977 May;29(5):298-303.

[The problem of polyneuropathy in methaqualone medication].

Psychiatrie, Neurologie, und medizinische Psychologie

[Article in German]
H J Kmietzyk, P Schröter, K Ernst

PMID: 882610

Abstract

Thirteen years after the introduction of methaqualone into therapy, investigators (namely, Finke, Spiegelberg, and Suchenwirth), by reference to individual cases, pointed out the possible development of polyneuropathies. This has not so far been confirmed despite worldwide use of the drug. Experiments on rats, which were conducted by the present authors, show a statistically significant decrease in maximum motor conduction speed, which is believed to be functional disorder. Clinical symptoms or nervous structural variations in the sense of polyneuropathy could not be observed.

Substances

MeSH terms

Publication Types